We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRSH
26
Marsh
MRSH
$91.4B
$129M 1.32%
1,579,916
+18,514
+1% +$1.54M
PFE icon
27
Pfizer
PFE
$142B
$112M 1.16%
3,269,854
-47,047
-1% -$1.6M
SRE icon
28
Sempra
SRE
$58.6B
$110M 1.13%
2,053,932
+403,670
+24% +$23.4M
PM icon
29
Philip Morris
PM
$299B
$108M 1.11%
1,018,513
-7,366
-0.7% -$785K
MXIM
30
DELISTED
Maxim Integrated Products
MXIM
$102M 1.05%
1,951,368
-13,250
-0.7% -$688K
BR icon
31
Broadridge
BR
$17.9B
$93.2M 0.96%
1,028,750
-22,028
-2% -$1.92M
ENB icon
32
Enbridge
ENB
$121B
$92.6M 0.95%
2,366,534
-1,593,356
-40% -$61.3M
USB icon
33
US Bancorp
USB
$98B
$92.4M 0.95%
1,725,055
-62,283
-3% -$3.35M
VTR icon
34
Ventas
VTR
$47.1B
$90.2M 0.93%
1,503,622
+28,586
+2% +$1.81M
LYB icon
35
LyondellBasell Industries
LYB
$19.5B
$89.6M 0.92%
812,564
-14,891
-2% -$1.54M
ADP icon
36
Automatic Data Processing
ADP
$105B
$86.4M 0.89%
736,851
-23,791
-3% -$2.72M
AAPL icon
37
Apple
AAPL
$4.9T
$82.1M 0.84%
1,940,312
-20,792
-1% -$869K
SYK icon
38
Stryker
SYK
$133B
$81.4M 0.84%
525,915
-9,679
-2% -$1.48M
HAS icon
39
Hasbro
HAS
$13.4B
$81.3M 0.84%
894,046
-8,683
-1% -$814K
ACN icon
40
Accenture
ACN
$99.9B
$79.1M 0.81%
516,509
+17,565
+4% +$2.55M
VLO icon
41
Valero Energy
VLO
$92.6B
$72.5M 0.75%
789,256
-8,107
-1% -$669K
WMB icon
42
Williams Companies
WMB
$86.7B
$69.9M 0.72%
2,294,158
-21,252
-0.9% -$618K
PNC icon
43
PNC Financial Services
PNC
$99.2B
$68.9M 0.71%
477,436
+34,830
+8% +$4.81M
MKC icon
44
McCormick & Company Non-Voting
MKC
$13.7B
$67.1M 0.69%
1,317,780
+87,770
+7% +$4.37M
CINF icon
45
Cincinnati Financial
CINF
$26.8B
$62.2M 0.64%
829,091
+253,062
+44% +$18.8M
CVX icon
46
Chevron
CVX
$383B
$61.1M 0.63%
487,848
+184,683
+61% +$21.9M
MRK icon
47
Merck
MRK
$321B
$57.6M 0.59%
1,073,232
-1,298,601
-55% -$72M
O icon
48
Realty Income
O
$60.1B
$56.4M 0.58%
1,020,746
+115,368
+13% +$6.26M
BDX icon
49
Becton Dickinson
BDX
$45.6B
$52.2M 0.54%
249,830
-2,287
-0.9% -$479K
INTC icon
50
Intel
INTC
$460B
$49.1M 0.5%
1,063,005
+11,117
+1% +$485K
1
2
3 4 5

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.